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Background
ALUMITES study was designed to assess the efficacy of
house dust mites (HDM: D. pteronyssinus + D. farinae)
subcutaneous immunotherapy for the treatment of aller-
gic rhinitis patients along one year. Here we report an
interim analysis done after 6 months of treatment.
Methods
In this controlled multicentre phase IV study, HDM
adult allergic patients were randomized to receive sub-
cutaneous immunotherapy with a 10 IR/ml depot
extract plus symptomatic treatment (group A) or only
symptomatic treatment (group B) (2:1). Acoustic rhino-
metry after nasal provocation test (NPT) was selected to
objectively assess the efficacy of this treatment by mea-
suring the nasal volume (NV) and minimum cross-sec-
tional area (MCA). A visual analogic scale (VAS) has
been used to subjectively assess the efficacy (0-10 scale,
lower is better)NPT consists in 5 determinations at
intervals of 15 minutes (basal, diluent, 0.01 IR, 0.1 IR, 1
IR) and one last determination 30 minutes after the last
administration. The extract used for the NPT was 100
IR/ml of D. pteronyssinus.
Results
Data from 38 of 57 patients were complete to be ana-
lyzed. MCA difference from baseline to six months visit
was 1.6 cm2 (95% CI: [-2.1, 5.3]) in active group and 0.8
cm2 (95% CI: [-4.3, 5.9]) in control group. NV difference
from baseline to six months visit was 37.1 cm3 (95% CI:
[-16.9, 91.2]) in active group and -5.8 cm3 (95% CI:
[-75.6, 64]) in control group. The analysis of covariance
(ANCOVA) showed statistical differences in basal deter-
mination of MCA after 6 months treatment (p=0.0001).
The symptoms score after the last provocation of 1 IR
measured by VAS from baseline to the six month visit
had a reduction of -2.4 points (95% CI: [-3.2, -1.6],
p<0.0001) in the active group whereas there was no sta-
tistical reduction in the control group: -0.7 points (95%
CI: [-2.5, 1.0], p=0.577).
Conclusion
Despite of the final low sample to analyze, efficacy is
demonstrated with six months of SCIT treatment with
10 IR/ml depot HDM extract that resulted in a signifi-
cant improve in clinical symptoms, this improvement
was not achieved by the control group. Objective assess-
ment of efficacy shows a clear positive trend in minimal
cross-sectional area determination.
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